A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HDAC / high-dose cytarabine

[Related PubMed/MEDLINE]
Total Number of Papers: 38
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HDAC  (>> Co-occurring Abbreviation)
Long Form:   high-dose cytarabine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 The epidemiology, treatment patterns, healthcare utilizations and costs of Acute Myeloid Leukaemia (AML) in Taiwan. AML, HSCT, N-SDAC, NCCN, NHIRD, SDAC, TCRD
2022 The favorable prognostic value of the loss of sex chromosomes in patients with t(8;21) acute myeloid leukemia: an exploratory study. AML, DFS, LOS, OS
2021 Evaluation of Empiric Vancomycin for Fevers During High-dose Cytarabine Administration. ---
2020 Clofarabine Improves Relapse-Free Survival of Acute Myeloid Leukemia in Younger Adults with Micro-Complex Karyotype. AML, CI, HR, RFS, SNP
2020 Postremission therapy with repeated courses of high-dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long-term outcome in European leukemia net favorable and intermediate-risk acute myeloid leukemia. AML, CR, NILG, OS, PBSC, RFS
2019 Comparison of neutropenia profiles in different treatment protocols for acute myeloid leukemia using the D-index. AML, DNR, IDR, SDAC
2019 [Fatal exacerbations of chronic active Epstein-Barr virus infection subsequent to cytotoxic chemotherapy]. CAEBV, HLH
2018 Impact of Consolidation Cycles Before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission. GVHD, HCT, HR
2018 Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001-2005 using the Japan Adult Leukemia Study Group AML201 protocols. AML, FN, JALSG
10  2018 Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens. AML, SAMHD1, USA
11  2017 A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabine. MSKCC, OS, PCNSL, PFS, R-MPV
12  2017 Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, aSingle-Institution Experience. AHCT, MCL
13  2017 Randomized Phase II Study of Clofarabine-Based Consolidation for Younger Adults With Acute Myeloid Leukemia in First Remission. AML, CLARA, HRs, RFS, SCT
14  2017 Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment. AML, APL, CBF, TKI
15  2015 Myeloid sarcoma of the breast in an aleukemic patient: a rare entity in an uncommon location. MS
16  2014 Acute myeloid leukemia after myelodysplastic syndrome and failure of therapy with hypomethylating agents: an emerging entity with a poor prognosis. AML, CR, MDS
17  2014 High-dose cytarabine in acute myeloid leukemia treatment: a systematic review and meta-analysis. AML, SDAC
18  2013 Irreversible neurological defects in the lower extremities after haploidentical stem cell transplantation: possible association with nelarabine. SCT
19  2009 Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapse. AML, CR, DSMB, OS
20  2009 [Prognosis and chromosomal abnormalities in 79 children with t (8;21) acute myeloid leukemia]. AML, CR, DA, DFS, EFS, HA, HAD, OS
21  2008 Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy. CR, KPS, MTX, OS, WBRT
22  2007 Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500). AML, CI, CR
23  2006 [Bulky lymphadenopathy in acute myeloid leukemia with inv (16) (p13q22): a case report]. AML, FISH, MRD
24  2005 Comparative efficacy and safety of gemtuzumab ozogamicin monotherapy and high-dose cytarabine combination therapy in patients with acute myeloid leukemia in first relapse. AML, CR, CRp
25  2004 Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995). AML, CR, PBSCT
26  2004 Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study. AML, ASCT, CIR, CR, DFS, IDAC
27  2004 Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461. AML, CIR, OS, RFS
28  2003 Adult patients with t(8;21) acute myeloid leukemia had no superior treatment outcome to those without t(8;21): a single institution's experience. AML, BMT, EFS, IDAC, OS
29  2002 Phase I trial with escalating doses of idarubicin and multidrug resistance reversal by short-course cyclosporin A, sequential high-dose cytosine arabinoside, and granulocyte colony-stimulating factor for adult patients with refractory acute leukemia. AML, ALL, CR, CsA, G-CSF, IDR, MDR1, MTD, RRT
30  2001 [Acute myeloid leukemia]. AML, APL, HSCT
31  2000 New approaches to acute lymphoblastic leukemia in adults: where do we go? 6-MP, ALL, CR, DLI, GVL, HDM, MRD, SCT
32  1997 Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. AML, CR, EML
33  1997 Post-remission therapy of adult acute myeloid leukaemia: one cycle of high-dose versus standard-dose cytarabine. Leukaemia Project Group of the Swiss Group for Clinical Cancer Research (SAKK). AML
34  1996 A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study. AML, CR, DFS, DNR, SDAC, SWOG
35  1996 Acute pancreatitis associated with continuous infusion cytarabine therapy: a case report. AML
36  1993 Cumulative chemotherapy increases mafosfamide toxicity for normal progenitor cells in AML patients: rationale for cryopreserving adapted-dose purged marrow early in first complete remission. AML, CR, MAFO
37  1990 Septicemia in pediatric oncology patients: the significance of viridans streptococcal infections. ---
38  1988 Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine. t-ANLL, t-MDS